Sangamo 3Q Loss Narrows On Payments, Lower Costs
Sangamo BioSciences' 3rd-quarter loss narrows on partnership payments, lower costs
10:01AM 11/05/09
Movers Roundup: KBR, Sangamo Biosciences
Movers roundup: KBR gains as analyst sees moves into energy, Sangamo Biosciences rises
02:42PM 08/25/09
Sangamo Rises Further On Sigma-Aldrich Study Plan
Sangamo Biosciences sustains Monday gains as analyst looks at Sigma-Aldrich licensing pact
01:31PM 08/25/09
Biotech Mailbag: Vertex Has Verve
The company's experimental hepatitis C drug telaprevir stands tall after taking some shots from
02:45PM 11/14/08
Biotech Mailbag: Vertex Has Verve (RealMoney.com $)
The company's experimental hepatitis C drug telaprevir stands tall after taking some shots from competitors.
07:02AM 11/14/08
Health Winners & Losers: Gilead
Cell Genesys tumbles 75% after the company terminates a second study on its prostate cancer vaccine.
03:31PM 10/16/08
Feuerstein's Biotech Mailbag: ImClone
Understandig the drug-rights fight between ImClone and Bristol. What about Sangamo's drug for treating diabetic nerve damage? And a big fat zero for Mannkind.
12:47PM 09/19/08
Feuerstein's Biotech Mailbag: ImClone (RealMoney.com $)
Understandig the drug-rights fight between ImClone and Bristol. What about Sangamo's drug for treating diabetic nerve damage? And a big fat zero for Mannkind.
07:41AM 09/19/08
Health Winners & Losers: AstraZeneca
AstraZeneca climbs on a MedImmune contract.
05:43PM 07/09/08
Biotech Stocks: Second-Half '08 Preview
Here are the data and regulatory decisions that are likely to be the biggest catalysts from July to December.
10:36AM 07/07/08
Feuerstein's Biotech-Stock Mailbag: Delcath
More discussion of Sangamo's SB-509, revisiting Delcath and questioning YM Bio's chances with nimo.
10:03AM 06/27/08
Biotech-Stock Mailbag: Sangamo, YM Biosciences (RealMoney.com $)
More discussion of Sangamo's SB-509, revisiting Delcath and questioning YM Bio's chances with nimo.
07:03AM 06/27/08
Biotech-Stock Mailbag: Sangamo
Weighing chances for Sangamo's lead pipeline drug, and more.
06:59AM 06/13/08
Thursday's Winners & Losers: Kosan Biosciences
Shares jump 228.5% on a report that Bristol-Myers Squibb will buy the company.
04:39PM 05/29/08



Connect with TheStreet